Diversity of Glycoprotein Deficiencies in Glanzmann’s Thrombasthenia

Summary

The platelet proteins of 9 thrombasthenic patients from 7 families were analysed by high resolution two-dimensional gel electrophoresis (HR-2DE) and crossed immunoelectrophoresis (CIE). In 7 patients both glycoproteins (GPs) IIb and Ilia were absent or reduced to roughly the same extent. In two related patients only a trace of GP Ilb-IIIa complex was detected in CIE, but HR-2DE revealed a glycopeptide in the position of GP Ilia in an amount comparable to type II thrombasthenia. This GP Ilia-like component was neither recognized normally by anti-GP Ilb-IIIa antibodies nor labeled by surface iodination. In unreduced-reduced two-dimensional gel electrophoresis two components were observed in the region of GP Ilia. The assumption of a structural variant of GP Ilia in the two related patients is discussed.

Keywords

Thrombasthenia - Platelet membrane glycoproteins - Glycoprotein IIb-IIIa complex

• References

• 1 Nurden AT, Caen JP. An abnormal platelet glycoprotein pattern in three cases of Glanzmann’s thrombasthenia. Br J Haematol 1974; 28: 253-260
• 2 Phillips DR, Agin PP. Platelet membrane defects in Glanzmann’s thrombasthenia: Evidence for decreased amounts of two major glycoproteins. J Clin Invest 1977; 60: 535-545
• 3 Nurden AT, Caen JP. The different glycoprotein abnormalities in thrombasthenic and Bernard-Soulier platelets. Semin Haematol 1979; 16: 234-250
• 4 Nachman RL, Leung LL K. Complex formation of platelet membrane glycoproteins lib and Ilia with fibrinogen. J Clin Invest 1982; 69: 263-269
• 5 Gogstad GO, Brosstad F, Krutnes MB, Hagen I, Solum NO. Fibrinogen-binding properties of the human platelet membrane glycoprotein Ilb-IIIa complex: A study using crossed-radioimmunoelec-trophoresis. Blood 1982; 60: 663-671
• 6 Bennet JS, Vilaire G, Cines DB. Identification of the fibrinogen receptor on human platelets by photoaffinity labeling. J Biol Chem 1982; 257: 8049-8054
• 7 Di Minno G, Thiagarajan P, Perussio B, Martinez J, Shapiro S, Triuchier G, Murphy S. Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: Inhibition by a monoclonal antibody to the glycoprotein Ilb-IIIa complex. Blood 1983; 61: 140-148
• 8 Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenia-like state in normal platelets and binds to glycoprotein lib and/or Ilia. J Clin Invest 1983 72: 325-338
• 9 Caen J. Glanzmann thrombasthenia. Clin Haematol 1972; 1: 383-392
• 10 Hagen I, Nurden AT, Bjerrum OJ, Solum NO, Caen JP. Immunological difference between type I and type II thrombasthenic platelets. Protides of the Biological fluids, 27th Coll 1979 ed. by Peeters H. Pergamon Press Oxford; New York: 1979: 875-878
• 11 Hagen I, Nurden AT, Bjerrum OJ, Solum NO, Caen JP. Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann’s thrombasthenia and Bernard-Soulier syndrome. J Clin Invest 1980; 65: 722-731
• 12 Holahan JR, White GC. Heterogeneity of membrane surface proteins in Glanzmann’s thrombasthenia. Blood 1981; 57: 174-181
• 13 Meyer M, Herrmann FH, Weissbach G, Wiedemann H, Lagutina NJ, Tchishova AI. Heterogenität der Protein- und Glykoproteinanoma-lien bei der hereditaren Thrombasthenie Glanzmann. Dt Gesundh-Wesen 1983; 38: 1614-1618
• 14 Herrmann FH, Meyer M, Gogstad GO, Solum NO. Glycoprotein Ilb-IIIa complex in platelets of patients and heterozygotes of Glanzmann’s thrombasthenia. Thromb Res 1983; 32: 615-622
• 15 Kunicki TJ, Nurden AT, Pidard D, Russell NR, Caen JP. Characterization of human platelet glycoprotein antigens giving rise to individual immunoprecipitates in crossed-immunoelectrophoresis. Blood 1981; 58: 1190-1197
• 16 Hagen I, Bjerrum OJ, Solum NO. Characterization of human platelet protein solubilized with Triton X-100 and examined by crossed immunoelectrophoresis. Eur J Biochem 1979; 99: 9-22
• 17 Kornecki E, Tuszynski GP, Niewarowski S. Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an M_r = 66,000 protein derived from glycoprotein Ilia. J Biol Chem 1983; 258: 9349-9356
• 18 Phillips DR, Agin PP. Platelet plasma membrane glycoproteins. Evidence for the presence of nonequivalent disulfide bonds using nonreduced-reduced two-dimensional gel electrophoresis. J Biol Chem 1977; 252: 2121-2126
• 19 Clemetson KJ, Capitanio A, Liischer EF. High resolution twodimensional gel electrophoresis of the proteins and glycoproteins of human blood platelets and platelet membrane. Biochim Biophys Acta 1979; 553: 11-24
• 20 Herrmann FH, Meyer M, Ihle E. Protein and glycoprotein abnormalities in an unusual subtype of Glanzmann’s thrombasthenia. Haemostasis 1982; 12: 337-344
• 21 Harboe N, Ingild A. Immunization, isolation of immunoglobulins, estimation of antibody titre. Scand J Immunol 1973; 2 Suppl (Suppl. 01) 161-164
• 22 George JN, Nurden AT, Phillips DR. Molecular defects in interactions of platelets with the vessel wall. N Engl J Med 1984; 311: 1084-1098
• 23 Nurden AT, Rosa JP, Boizard B, Didry D, Legrand C, Parquet A. Evidence that GP Ilb-IIIa complexes are required for ADP-induced platelet aggregation from studies on the platelets of a patient with a new type of Glanzmann’s thrombasthenia. Thromb Haemostas 1983; 50: 216 Abstr
• 24 Caen JP, Rosa JP, Soria C, Boizard B. Variant de thrombasthenie Paris-I Lariboisire, anomalie moléculaire du complexe glycoproteini-que plaquettaire Ilb-IIIa. C R Acad Sci Paris 1983; 296: 479-481